ArticleJournal of clinical medicine2026

Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.

Meral Ulukoylu Menguc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.